Heartflow (HTFL) EBIT (2024 - 2025)

Heartflow's (HTFL) quarterly EBIT came in at -$17.8 million in Q4 2025, down 10.54% year-on-year from -$19.8 million in Q4 2024, and down 17.56% quarter-over-quarter from -$15.1 million in Q3 2025.

Heartflow (HTFL) EBIT (2024 - 2025) Analysis & Trends

Heartflow's EBIT history runs 2 years deep, the most recent figure standing at -$17.8 million for Q4 2025.

  • On a quarterly basis, EBIT fell 10.54% year-over-year to -$17.8 million in Q4 2025; TTM through Dec 2025 was -$62.6 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$64.1 million, down 4.65% from the prior year.
  • EBIT slipped to -$17.8 million in Q4 2025 per HTFL's latest filing, from -$15.1 million in the prior quarter.
  • Across five years, EBIT topped out at -$13.7 million in Q2 2025 and bottomed at -$17.8 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Veeva Systems 29.34 Bn 22.03 Bn 662.02 Mn 273.11 Mn
2 BrightSpring Health Services 13.49 Bn 12.59 Bn 482.22 Mn 121.45 Mn
3 Healthequity 7.96 Bn 7.70 Bn 256.31 Mn 102.95 Mn
4 10x Genomics 6.17 Bn 5.63 Bn 106.18 Mn -17.05 Mn
5 Hinge Health 6.02 Bn 5.70 Bn 154.23 Mn 32.07 Mn
6 MiniMed 4.19 Bn 3.89 Bn 480.00 Mn -93.00 Mn
7 Waystar Holding 4.14 Bn 4.07 Bn 216.84 Mn 80.47 Mn
8 Doximity 3.82 Bn 3.08 Bn 125.97 Mn 24.83 Mn
9 Privia Health 3.10 Bn 2.73 Bn - 7.42 Mn
10 Heartflow 906.97 Mn 730.19 Mn 39.06 Mn -17.75 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -17.75 Mn
Sep 30, 2025 -15.10 Mn
Jun 30, 2025 -13.72 Mn
Dec 31, 2024 -16.06 Mn
Sep 30, 2024 -14.93 Mn
Jun 30, 2024 -14.18 Mn